NANOVIRICIDES, INC. Share-based Payment Arrangement, Noncash Expense
NANOVIRICIDES, INC. (NNVC) reported Share-based Payment Arrangement, Noncash Expense of $35.76 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2021-10-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-10-12
- NANOVIRICIDES, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $23.84K.
- NANOVIRICIDES, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $35.76K.
- NANOVIRICIDES, INC. share-based payment arrangement, noncash expense for the quarter ending 2018-12-31 was $0.00.
- NANOVIRICIDES, INC. share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $11.92K.
- NANOVIRICIDES, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $35.76K, a 77.10% decline from fiscal 2018.
- NANOVIRICIDES, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $156.19K.
- NANOVIRICIDES, INC. share-based payment arrangement, noncash expense for fiscal 2016 was $158.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-06-30 | $23.84K derived: 10-K 12 month − 10-K 9 month · filed 2021-10-12 | $59.60K derived: sum of 2 quarters · filed 2021-10-12 | $59.60K derived: sum of 3 quarters · filed 2021-10-12 | $35.76K 10-K · filed 2021-10-12 |
| 2019-03-31 | $35.76K 10-K · filed 2019-08-23 | $35.76K derived: sum of 2 quarters · filed 2019-08-23 | $11.92K 10-K · filed 2019-08-23 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | $11.92K 10-Q · filed 2019-02-14 | ||
| 2018-09-30 | $11.92K 10-Q · filed 2018-11-14 | |||
| 2018-06-30 | $156.19K 10-K · filed 2018-10-12 | |||
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | $0.00 10-Q · filed 2019-02-14 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 | |||
| 2016-06-30 | $158.00K 10-K · filed 2018-10-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |